BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Godkin A, Davenport M, Hill AV. Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness. Hepatology. 2005;41:1383-1390. [PMID: 15915462 DOI: 10.1002/hep.20716] [Cited by in Crossref: 92] [Cited by in F6Publishing: 87] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Du T, Guo XH, Zhu XL, Li JH, Lu LP, Gao JR, Gou CY, Li Z, Liu Y, Li H. Association of TNF-alpha promoter polymorphisms with the outcomes of hepatitis B virus infection in Chinese Han population. J Viral Hepat. 2006;13:618-624. [PMID: 16907849 DOI: 10.1111/j.1365-2893.2006.00731.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 2.8] [Reference Citation Analysis]
2 Chou HH, Chien WH, Wu LL, Cheng CH, Chung CH, Horng JH, Ni YH, Tseng HT, Wu D, Lu X, Wang HY, Chen PJ, Chen DS. Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota. Proc Natl Acad Sci USA. 2015;112:2175-2180. [PMID: 25646429 DOI: 10.1073/pnas.1424775112] [Cited by in Crossref: 110] [Cited by in F6Publishing: 97] [Article Influence: 15.7] [Reference Citation Analysis]
3 Wiegand J, Meya S, Schlaphoff V, Manns MP, Mössner J, Wedemeyer H, Tillmann HL. HBV-specific T-cell responses in healthy seronegative sexual partners of patients with chronic HBV infection. J Viral Hepat 2010;17:631-9. [PMID: 19889141 DOI: 10.1111/j.1365-2893.2009.01220.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
4 Therrien A, Kelly CP, Silvester JA. Celiac Disease: Extraintestinal Manifestations and Associated Conditions. J Clin Gastroenterol 2020;54:8-21. [PMID: 31513026 DOI: 10.1097/MCG.0000000000001267] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
5 Yang C, Pan L, Zhang L, Wu X, Zhu X, Yan B, Xu A, Li H, Liu Y. BTNL2 associated with the immune response to hepatitis B vaccination in a Chinese Han population: BTNL2 and Immune Response to HBV Vaccination. J Med Virol 2014;86:1105-12. [DOI: 10.1002/jmv.23934] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
6 Yue Q, Hu X, Yin W, Xu X, Wei S, Lei Y, Lü X, Yang J, Su M, Xu Z. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice. J Virol Methods. 2007;141:41-48. [PMID: 17197041 DOI: 10.1016/j.jviromet.2006.11.025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
7 Leonardi S, Praticò AD, Lionetti E, Spina M, Vitaliti G, Rosa ML. Intramuscular vs intradermal route for hepatitis B booster vaccine in celiac children. World J Gastroenterol 2012; 18(40): 5729-5733 [PMID: 23155313 DOI: 10.3748/wjg.v18.i40.5729] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
8 Wei LZ, Wang HL, Liu X, Lu YP, Xu F, Yuan JQ, Ling YQ. Meta-analysis on the relationship between HLA-DRBl gene polymorphism and cervical cancer in Chinese population. PLoS One 2014;9:e88439. [PMID: 24551099 DOI: 10.1371/journal.pone.0088439] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
9 Zingone F, Morisco F, Zanetti A, Romanò L, Portella G, Capone P, Andreozzi P, Tortora R, Ciacci C. Long-term antibody persistence and immune memory to hepatitis B virus in adult celiac patients vaccinated as adolescents. Vaccine. 2011;29:1005-1008. [PMID: 21129395 DOI: 10.1016/j.vaccine.2010.11.060] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
10 Han B, Liu W, Du J, Liu H, Zhao T, Yang S, Wang S, Zhang S, Liu B, Liu Y, Cui F. 12 Months Persistent Immunogenicity after Hepatitis B Vaccination in Patients with Type 2 Diabetes and Immunogenicity of Revaccination in Non-Responders: An Open-Label Randomized Controlled Trial. Vaccines (Basel) 2021;9:1407. [PMID: 34960153 DOI: 10.3390/vaccines9121407] [Reference Citation Analysis]
11 Qiu S, He P, Fang X, Tong H, Lv J, Liu J, Zhang L, Zhai X, Wang L, Hu Z, Yu Y. Significant transcriptome and cytokine changes in hepatitis B vaccine non-responders revealed by genome-wide comparative analysis. Hum Vaccin Immunother. 2018;14:1763-1772. [PMID: 29580160 DOI: 10.1080/21645515.2018.1450122] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
12 Mackay IR. Genetic susceptibility to chronic hepatitis B virus infection. J Gastroenterol Hepatol. 2006;21:1087-1088. [PMID: 16824056 DOI: 10.1111/j.1440-1746.2006.04430.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
13 Hu L, Zhai X, Liu J, Chu M, Pan S, Jiang J, Zhang Y, Wang H, Chen J, Shen H. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hepatology. 2012;55:1426-1431. [PMID: 22105689 DOI: 10.1002/hep.24799] [Cited by in Crossref: 123] [Cited by in F6Publishing: 126] [Article Influence: 12.3] [Reference Citation Analysis]
14 Gong JJ, Margolis DJ, Monos DS. Predictive in silico binding algorithms reveal HLA specificities and autoallergen peptides associated with atopic dermatitis. Arch Dermatol Res 2020;312:647-56. [PMID: 32152724 DOI: 10.1007/s00403-020-02059-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Zheng L, Li D, Wang F, Wu H, Li X, Fu J, Chen X, Wang L, Liu Y, Wang S. Association between hepatitis B viral burden in chronic infection and a functional single nucleotide polymorphism of the PDCD1 gene. J Clin Immunol. 2010;30:855-860. [PMID: 20700634 DOI: 10.1007/s10875-010-9450-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
16 Gao X, Liu W, Zhang X, Tang L, Wang L, Yan L, Yang H, Li T, Yang L, Ma N, Liu D. Genetic polymorphism of HLA-DQ confers susceptibility to hepatitis B virus-related hepatocellular carcinoma: a case-control study in Han population in China. Tumour Biol 2016;37:12103-11. [PMID: 27209411 DOI: 10.1007/s13277-016-5077-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
17 Seshasubramanian V, Soundararajan G, Ramasamy P. Human leukocyte antigen A, B and Hepatitis B infection outcome: A meta-analysis. Infect Genet Evol 2018;66:392-8. [PMID: 28757339 DOI: 10.1016/j.meegid.2017.07.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
18 Akbar SM, Al-mahtab M, Khan SI, Shrestha A, Tabassum S, Hiasa Y. Current trends in hepatitis B vaccination. Future Virology 2016;11:369-78. [DOI: 10.2217/fvl-2016-0025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Aggeletopoulou I, Davoulou P, Konstantakis C, Thomopoulos K, Triantos C. Response to hepatitis B vaccination in patients with liver cirrhosis. Rev Med Virol. 2017;27. [PMID: 28905444 DOI: 10.1002/rmv.1942] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
20 Moorman JP, Zhang CL, Ni L, Ma CJ, Zhang Y, Wu XY, Thayer P, Islam TM, Borthwick T, Yao ZQ. Impaired hepatitis B vaccine responses during chronic hepatitis C infection: involvement of the PD-1 pathway in regulating CD4(+) T cell responses. Vaccine 2011;29:3169-76. [PMID: 21376795 DOI: 10.1016/j.vaccine.2011.02.052] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 4.0] [Reference Citation Analysis]
21 He YL, Zhao YR, Zhang SL, Lin SM. Host susceptibility to persistent hepatitis B virus infection. World J Gastroenterol 2006; 12(30): 4788-4793 [PMID: 16937459 DOI: 10.3748/wjg.v12.i30.4788] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
22 Jafarzadeh A, Zarei S, Shokri F. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates. Vaccine 2008;26:269-76. [DOI: 10.1016/j.vaccine.2007.10.044] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
23 Yao ZQ, Moorman JP. Immune exhaustion and immune senescence: two distinct pathways for HBV vaccine failure during HCV and/or HIV infection. Arch Immunol Ther Exp (Warsz). 2013;61:193-201. [PMID: 23400275 DOI: 10.1007/s00005-013-0219-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
24 Yan ZH, Fan Y, Wang XH, Mao Q, Deng GH, Wang YM. Relationship between HLA-DR gene polymorphisms and outcomes of hepatitis B viral infections: A meta-analysis. World J Gastroenterol 2012; 18(24): 3119-3128 [PMID: 22791948 DOI: 10.3748/wjg.v18.i24.3119] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
25 Kim H, Ko C, Lee JY, Kim M. Current Progress in the Development of Hepatitis B Virus Capsid Assembly Modulators: Chemical Structure, Mode-of-Action and Efficacy. Molecules 2021;26:7420. [PMID: 34946502 DOI: 10.3390/molecules26247420] [Reference Citation Analysis]
26 Walayat S, Ahmed Z, Martin D, Puli S, Cashman M, Dhillon S. Recent advances in vaccination of non-responders to standard dose hepatitis B virus vaccine. World J Hepatol 2015; 7(24): 2503-2509 [PMID: 26523203 DOI: 10.4254/wjh.v7.i24.2503] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 6.4] [Reference Citation Analysis]
27 Akgöllü E, Bilgin R, Akkız H, Ülger Y, Kaya BY, Karaoğullarından Ü, Arslan YK. Association between chronic hepatitis B virus infection and HLA-DP gene polymorphisms in the Turkish population. Virus Res 2017;232:6-12. [PMID: 28119119 DOI: 10.1016/j.virusres.2017.01.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
28 Wu JF, Chen CH, Hsieh RP, Shih HH, Chen YH, Li CR, Chiang CY, Shau WY, Ni YH, Chen HL. HLA typing associated with hepatitis B E antigen seroconversion in children with chronic hepatitis B virus infection: a long-term prospective sibling cohort study in Taiwan. J Pediatr. 2006;148:647-651. [PMID: 16737879 DOI: 10.1016/j.jpeds.2005.12.025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
29 Akgöllü E. Assessment of HLADP gene rs3128917 and rs9380343 polymorphisms in chronic HBV infection. Turk J Gastroenterol 2019;30:616-23. [PMID: 31290749 DOI: 10.5152/tjg.2019.18480] [Reference Citation Analysis]
30 Zuckerman JN. Vaccination against hepatitis A and B: developments, deployment and delusions. Current Opinion in Infectious Diseases 2006;19:456-9. [DOI: 10.1097/01.qco.0000244051.23511.09] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
31 Guo X, Zhang Y, Li J, Ma J, Wei Z, Tan W, O’Brien SJ. Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population. Hepatology. 2011;53:422-428. [PMID: 21274863 DOI: 10.1002/hep.24048] [Cited by in Crossref: 95] [Cited by in F6Publishing: 104] [Article Influence: 8.6] [Reference Citation Analysis]
32 Xu B, Zhu D, Bi Y, Wang Y, Hu Y, Zhou YH. Minimal association of alleles of human leukocyte antigen class II gene and long-term antibody response to hepatitis B vaccine vaccinated during infancy. Vaccine 2017;35:2457-62. [PMID: 28320591 DOI: 10.1016/j.vaccine.2017.03.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
33 Yucesoy B, Talzhanov Y, Johnson VJ, Wilson NW, Biagini RE, Wang W, Frye B, Weissman DN, Germolec DR, Luster MI, Barmada MM. Genetic variants within the MHC region are associated with immune responsiveness to childhood vaccinations. Vaccine 2013;31:5381-91. [PMID: 24075919 DOI: 10.1016/j.vaccine.2013.09.026] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
34 Blackwell JM, Jamieson SE, Burgner D. HLA and infectious diseases. Clin Microbiol Rev. 2009;22:370-385, Table of Contents. [PMID: 19366919 DOI: 10.1128/CMR.00048-08] [Cited by in Crossref: 196] [Cited by in F6Publishing: 100] [Article Influence: 15.1] [Reference Citation Analysis]
35 Vitaliti G, Praticò AD, Cimino C, Di Dio G, Lionetti E, La Rosa M, Leonardi S. Hepatitis B vaccine in celiac disease: Yesterday, today and tomorrow. World J Gastroenterol 2013; 19(6): 838-845 [PMID: 23430309 DOI: 10.3748/wjg.v19.i6.838] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
36 Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH, Sun Y, Xuan SY. Association between HLA-DRB1 alleles polymorphism and hepatocellular carcinoma: a meta-analysis. BMC Gastroenterol. 2010;10:145. [PMID: 21172035 DOI: 10.1186/1471-230X-10-145.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Hou SH, Hu J, Zhang Y, Li QL, Guo JJ. Effects of interaction between genetic variants in human leukocyte antigen DQ and granulysin genes in Chinese Han subjects infected with hepatitis B virus. Microbiol Immunol. 2015;59:209-218. [PMID: 25644528 DOI: 10.1111/1348-0421.12239] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
38 Liu Z, Huang CJ, Huang YH, Pan MH, Lee MH, Yu KJ, Pfeiffer RM, Viard M, Yuki Y, Gao X, Carrington M, Chen CJ, Hildesheim A, Yang HI; REVEAL-HBV Study Group. HLA zygosity increases risk of hepatitis B virus-associated hepatocellular carcinoma. J Infect Dis 2021:jiab207. [PMID: 33852009 DOI: 10.1093/infdis/jiab207] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Choga WT, Anderson M, Zumbika E, Phinius BB, Mbangiwa T, Bhebhe LN, Baruti K, Kimathi PO, Seatla KK, Musonda RM, Bell TG, Moyo S, Blackard JT, Gaseitsiwe S. In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in Botswana. Viruses 2020;12:E731. [PMID: 32640609 DOI: 10.3390/v12070731] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Nishida N, Sawai H, Matsuura K, Sugiyama M, Ahn SH, Park JY, Hige S, Kang JH, Suzuki K, Kurosaki M. Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean. PLoS One. 2012;7:e39175. [PMID: 22737229 DOI: 10.1371/journal.pone.0039175] [Cited by in Crossref: 105] [Cited by in F6Publishing: 110] [Article Influence: 10.5] [Reference Citation Analysis]
41 Huang YH, Liao SF, Khor SS, Lin YJ, Chen HY, Chang YH, Huang YH, Lu SN, Lee HW, Ko WY, Huang C, Liu PC, Chen YJ, Wu PF, Chu HW, Wu PE, Tokunaga K, Shen CY, Lee MH. Large-scale genome-wide association study identifies HLA class II variants associated with chronic HBV infection: a study from Taiwan Biobank. Aliment Pharmacol Ther 2020;52:682-91. [PMID: 32573827 DOI: 10.1111/apt.15887] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
42 Zhang SY, Li XK, Dong GL, Yang SF, Gu HX, Li D, Jin Q, Liu W, Du B, Lu B. Correlation of hepatitis B virus YMDD mutations with the polymorphism of HLA alleles in patients with chronic hepatitis B virus infection. Shijie Huaren Xiaohua Zazhi 2006; 14(29): 2854-2859 [DOI: 10.11569/wcjd.v14.i29.2854] [Reference Citation Analysis]
43 Ertem D, Gonen I, Tanidir C, Ugras M, Yildiz A, Pehlivanoğlu E, Eksioglu-Demiralp E. The response to hepatitis B vaccine: does it differ in celiac disease? Eur J Gastroenterol Hepatol 2010;22:787-93. [PMID: 19584738 DOI: 10.1097/MEG.0b013e32832e9d41] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
44 Pajot A, Michel ML, Mancini-Bourgine M, Ungeheuer MN, Ojcius DM, Deng Q, Lemonnier FA, Lone YC. Identification of novel HLA-DR1-restricted epitopes from the hepatitis B virus envelope protein in mice expressing HLA-DR1 and vaccinated human subjects. Microbes Infect. 2006;8:2783-2790. [PMID: 17045504 DOI: 10.1016/j.micinf.2006.08.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
45 He Y, Zhao Y, Zhang S, Chen W, Lin S, Yang Q, Liu J, Yang Y, Jin Y, Liu M. Not polymorphism but methylation of class II transactivator gene promoter IV associated with persistent HBV infection. Journal of Clinical Virology 2006;37:282-6. [DOI: 10.1016/j.jcv.2006.08.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
46 Pan L, Zhang L, Zhang W, Wu X, Li Y, Yan B, Zhu X, Liu X, Yang C, Xu J. A genome-wide association study identifies polymorphisms in the HLA-DR region associated with non-response to hepatitis B vaccination in Chinese Han populations. Hum Mol Genet. 2014;23:2210-2219. [PMID: 24282030 DOI: 10.1093/hmg/ddt586] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
47 Zhang XL, Ni XC, Jia JH, Dong JH, Yu FX, Ma N, Liu XH, Li M, Liu DW. Association of the rs3077 and rs9277535 polymorphisms in HLA-DP with hepatitis B virus infection and spontaneous clearance: a meta-analysis. Scand J Gastroenterol. 2013;48:736-744. [PMID: 23601003 DOI: 10.3109/00365521.2013.787643] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
48 Liu X, Zhang L, Wu XP, Zhu XL, Pan LP, Li T, Yan BY, Xu AQ, Li H, Liu Y. Polymorphisms in IRG1 gene associated with immune responses to hepatitis B vaccination in a Chinese Han population and function to restrain the HBV life cycle. J Med Virol 2017;89:1215-23. [PMID: 28004399 DOI: 10.1002/jmv.24756] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
49 Mobini S, Chizari M, Mafakher L, Rismani E, Rismani E. Computational Design of a Novel VLP-Based Vaccine for Hepatitis B Virus. Front Immunol 2020;11:2074. [PMID: 33042118 DOI: 10.3389/fimmu.2020.02074] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
50 Soejima Y, Ikegami T, Taketomi A, Yoshizumi T, Uchiyama H, Harada N, Yamashita Y, Maehara Y. Hepatitis B vaccination after living donor liver transplantation. Liver Int 2007;27:977-82. [DOI: 10.1111/j.1478-3231.2007.01521.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
51 Panigrahi R, Sarkar N, Biswas A, Pal A, Saha D, Singh SP, Panigrahi MK, Bandopadhyay M, Chakrabarti S, Chakravarty R. Association of TNF-α Promoter Polymorphism with HBV Associated Disease Outcome Among HBV Infected Patients from Orissa, Southern Part of East India. J Clin Exp Hepatol 2014;4:202-8. [PMID: 25755561 DOI: 10.1016/j.jceh.2014.08.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
52 Albayrak A, Ertek M, Tasyaran MA, Pirim I. Role of HLA allele polymorphism in chronic hepatitis B virus infection and HBV vaccine sensitivity in patients from eastern Turkey. Biochem Genet. 2011;49:258-269. [PMID: 21188498 DOI: 10.1007/s10528-010-9404-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
53 Filippelli M, Lionetti E, Pulvirenti A, Gennaro A, Lanzafame A, Marseglia GL, Salpietro C, Rosa ML, Leonardi S. New approaches in hepatitis B vaccination for celiac disease. Immunotherapy. 2014;6:945-952. [PMID: 25313572 DOI: 10.2217/imt.14.64] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
54 Seto WK, Wong DK, Kopaniszen M, Proitsi P, Sham PC, Hung IF, Fung J, Lai CL, Yuen MF. HLA-DP and IL28B polymorphisms: influence of host genome on hepatitis B surface antigen seroclearance in chronic hepatitis B. Clin Infect Dis. 2013;56:1695-1703. [PMID: 23449268 DOI: 10.1093/cid/cit121] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 5.2] [Reference Citation Analysis]
55 Anania C, Olivero F, Spagnolo A, Chiesa C, Pacifico L. Immune response to vaccines in children with celiac disease. World J Gastroenterol 2017; 23(18): 3205-3213 [PMID: 28566880 DOI: 10.3748/wjg.v23.i18.3205] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
56 Zhu X, Du T, Wu X, Guo X, Niu N, Pan L, Xin Z, Wang L, Li Z, Li H. Human leukocyte antigen class I and class II genes polymorphisms might be associated with interferon α therapy efficiency of chronic hepatitis B. Antiviral Res. 2011;89:189-192. [PMID: 21241740 DOI: 10.1016/j.antiviral.2011.01.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
57 Wong DK, Watanabe T, Tanaka Y, Seto WK, Lee CK, Fung J, Lin CK, Huang FY, Lai CL, Yuen MF. Role of HLA-DP polymorphisms on chronicity and disease activity of hepatitis B infection in Southern Chinese. PLoS One. 2013;8:e66920. [PMID: 23825586 DOI: 10.1371/journal.pone.0066920] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
58 Li X, Xu J, Lv Z, Wang J, Sun S, Zhu W, Wang B, He R, Qu D. Inadequate activation of the HBsAg-specific Th cells by APCs leads to hyporesponsiveness to HBsAg vaccine in B10.S mice. Hum Vaccin Immunother 2015;11:1735-43. [PMID: 26084003 DOI: 10.1080/21645515.2015.1048408] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
59 Kanduc D, Shoenfeld Y. From HBV to HPV: Designing vaccines for extensive and intensive vaccination campaigns worldwide. Autoimmunity Reviews 2016;15:1054-61. [DOI: 10.1016/j.autrev.2016.07.030] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
60 Liu JY, Yang J, Jia HY. Differences in peripheral T-cell subsets among different clinical types of hepatitis B patients. Shijie Huaren Xiaohua Zazhi 2009; 17(29): 3038-3042 [DOI: 10.11569/wcjd.v17.i29.3038] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 Perng GC, Chokephaibulkit K. Immunologic hypo- or non-responder in natural dengue virus infection. J Biomed Sci 2013;20:34. [PMID: 23725050 DOI: 10.1186/1423-0127-20-34] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
62 Zanoni G, Contreas G, Valletta E, Gabrielli O, Mengoli C, Veneri D. Normal or defective immune response to Hepatitis B vaccine in patients with diabetes and celiac disease. Hum Vaccin Immunother. 2015;11:58-62. [PMID: 25483516 DOI: 10.4161/hv.34309] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
63 Kafeero HM, Ndagire D, Ocama P, Walusansa A, Sendagire H. Tumor Necrosis Factor-α-863C/A and 1031 T/C Single nucleotide polymorphic sites (SNPs) may be putative markers of HBV disease prognosis among Caucasoids: Evidence from a systematic review with meta-analysis. Gene Reports 2022;26:101486. [DOI: 10.1016/j.genrep.2021.101486] [Reference Citation Analysis]
64 Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH, Sun Y, Xuan SY. Association between HLA-DRB1 alleles polymorphism and hepatocellular carcinoma: a meta-analysis. BMC Gastroenterol. 2010;10:145. [PMID: 21172035 DOI: 10.1186/1471-230X-10-145] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
65 Shi L, Wang JM, Ren JP, Cheng YQ, Ying RS, Wu XY, Lin SM, Griffin JW, Li GY, Moorman JP. KLRG1 impairs CD4+ T cell responses via p16ink4a and p27kip1 pathways: role in hepatitis B vaccine failure in individuals with hepatitis C virus infection. J Immunol. 2014;192:649-657. [PMID: 24337749 DOI: 10.4049/jimmunol.1302069] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
66 Trovato CM, Montuori M, Sansone A, Morelli A, Russo G, Pietropaoli N, Oliva S. Association between Elevated TGA-IgA Titers and Older Age at Diagnosis with Absence of HBV Seroconversion in Celiac Children. Vaccines (Basel) 2021;9:101. [PMID: 33525661 DOI: 10.3390/vaccines9020101] [Reference Citation Analysis]
67 Leonardi S, Spina M, Spicuzza L, Rotolo N, La Rosa M. Hepatitis B vaccination failure in celiac disease: Is there a need to reassess current immunization strategies? Vaccine 2009;27:6030-3. [DOI: 10.1016/j.vaccine.2009.07.099] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
68 Saraceni C, Birk J. A Review of Hepatitis B Virus and Hepatitis C Virus Immunopathogenesis. J Clin Transl Hepatol 2021;9:409-18. [PMID: 34221927 DOI: 10.14218/JCTH.2020.00095] [Reference Citation Analysis]
69 Mai H, Chen J, Chen H, Liu Z, Huang G, Wang J, Xiao Q, Ren W, Zhou B, Hou J, Jiang D. Fine Mapping of the MHC Region Identifies Novel Variants Associated with HBV-Related Hepatocellular Carcinoma in Han Chinese. J Hepatocell Carcinoma 2021;8:951-61. [PMID: 34430511 DOI: 10.2147/JHC.S321919] [Reference Citation Analysis]
70 Leonardi S, Vitaliti G, Garozzo MT, Miraglia del Giudice M, Marseglia G, La Rosa M. Hepatitis B vaccination failure in children with diabetes mellitus? The debate continues. Hum Vaccin Immunother. 2012;8:448-452. [PMID: 22370513 DOI: 10.4161/hv.19107] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
71 Xu YY, Yu JY, Zhong YW, Song HB, Liu HH, Jia LL, Li SL, Xu JQ, Li Q. Association between the frequency of class II HLA antigens and the susceptibility to intrauterine infection of hepatitis B virus. Int J Biol Sci 2008;4:111-5. [PMID: 18463715 DOI: 10.7150/ijbs.4.111] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
72 Zhang TC, Zhao YQ, Hu GL, Liu XQ, Huang XK. The relationship between tumour necrosis factor-α gene polymorphism and susceptibility and clearance of the persistent hepatitis B virus infection in a Chinese population: a meta-analysis. Clin Microbiol Infect. 2014;20:227-234. [PMID: 23701172 DOI: 10.1111/1469-0691.12257] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
73 Gao F, Zhang Y, Wang LK, Wei YL, Wang JW, Wang CB, Li Q. A meta-analysis of the correlation between the HLA-DRB1*03 allele and chronic hepatitis B in the Han Chinese population. Genet Test Mol Biomarkers 2015;19:218-21. [PMID: 25325831 DOI: 10.1089/gtmb.2014.0096] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
74 Zhang SY, Li D, Gu HX, Li XK, Jin X, Liu W, Du B, Lu B. Analysis of the polymorphism of human leukocyte antigen (HLA) class and class alleles in HBV infection. Shijie Huaren Xiaohua Zazhi 2006; 14(10): 963-968 [DOI: 10.11569/wcjd.v14.i10.963] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
75 Li HY, Wu JZ, Wu JL, Pang Y, Jiang CY, Qin L, Wei KL. Association between HLA-DRB1*11/14 alleles and HBV-related liver diseases. Shijie Huaren Xiaohua Zazhi 2012; 20(28): 2672-2677 [DOI: 10.11569/wcjd.v20.i28.2672] [Reference Citation Analysis]
76 Vierling JM. The immunology of hepatitis B. Clin Liver Dis. 2007;11:727-759, vii-viii. [PMID: 17981227 DOI: 10.1016/j.cld.2007.08.001] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 3.4] [Reference Citation Analysis]
77 Desombere I, Willems A, Gijbels Y, Leroux-Roels G. Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen. J Virol. 2006;80:3506-3514. [PMID: 16537618 DOI: 10.1128/jvi.80.7.3506-3514.2006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
78 Li S, Qian J, Yang Y, Zhao W, Dai J, Bei JX, Foo JN, McLaren PJ, Li Z, Yang J. GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS Genet. 2012;8:e1002791. [PMID: 22807686 DOI: 10.1371/journal.pgen.1002791] [Cited by in Crossref: 128] [Cited by in F6Publishing: 130] [Article Influence: 12.8] [Reference Citation Analysis]
79 Yan Z, Tan S, Dan Y, Sun X, Deng G, Wang Y. Relationship between HLA-DP gene polymorphisms and clearance of chronic hepatitis B virus infections: case-control study and meta-analysis. Infect Genet Evol. 2012;12:1222-1228. [PMID: 22543033 DOI: 10.1016/j.meegid.2012.03.026] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
80 Li J, Yang D, He Y, Wang M, Wen Z, Liu L, Yao J, Matsuda K, Nakamura Y, Yu J. Associations of HLA-DP variants with hepatitis B virus infection in southern and northern Han Chinese populations: a multicenter case-control study. PLoS One. 2011;6:e24221. [PMID: 21904616 DOI: 10.1371/journal.pone.0024221] [Cited by in Crossref: 41] [Cited by in F6Publishing: 47] [Article Influence: 3.7] [Reference Citation Analysis]
81 Wang Y, Xu P, Zhu D, Zhang S, Bi Y, Hu Y, Zhou YH. Association of polymorphisms of cytokine and TLR-2 genes with long-term immunity to hepatitis B in children vaccinated early in life. Vaccine. 2012;30:5708-5713. [PMID: 22824342 DOI: 10.1016/j.vaccine.2012.07.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
82 Moreno Mayordomo R, López Ramos I, Ortiz de Lejarazu Leonardo R. Human genetics ability to predict the risk of suffering an infectious disease. Med Clin (Barc) 2017;149:32-5. [PMID: 28476454 DOI: 10.1016/j.medcli.2017.03.025] [Reference Citation Analysis]
83 Kakisaka K, Sakai A, Yoshida Y, Miyasaka A, Takahashi F, Sumazaki R, Takikawa Y. Hepatitis B Surface Antibody Titers at One and Two Years after Hepatitis B Virus Vaccination in Healthy Young Japanese Adults. Intern Med 2019;58:2349-55. [PMID: 31118375 DOI: 10.2169/internalmedicine.2231-18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
84 Zhang X, Jia J, Dong J, Yu F, Ma N, Li M, Liu X, Liu W, Li T, Liu D. HLA-DQ polymorphisms with HBV infection: different outcomes upon infection and prognosis to lamivudine therapy. J Viral Hepat. 2014;21:491-498. [PMID: 24750255 DOI: 10.1111/jvh.12159] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
85 Pati NT, Sukriti, Hissar S, Agrawal K, Rani R, Sarin SK. Decrease in CD4+ T lymphocyte proliferation responses and enhanced CD150 cell expression in health care workers non-responsive to HBV vaccine. Vaccine 2007;25:1848-55. [PMID: 17240488 DOI: 10.1016/j.vaccine.2006.10.041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
86 Noizat-Pirenne F, Tournamille C, Bierling P, Roudot-Thoraval F, Le Pennec PY, Rouger P, Ansart-Pirenne H. Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class II restriction analysis. Transfusion 2006;46:1328-33. [PMID: 16934068 DOI: 10.1111/j.1537-2995.2006.00900.x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 5.1] [Reference Citation Analysis]
87 Copley HC, Gragert L, Leach AR, Kosmoliaptsis V. Influence of HLA Class II Polymorphism on Predicted Cellular Immunity Against SARS-CoV-2 at the Population and Individual Level. Front Immunol 2021;12:669357. [PMID: 34349756 DOI: 10.3389/fimmu.2021.669357] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Constantinescu I, Boșcaiu V, Cianga P, Dinu AA, Gai E, Melinte M, Moise A. The frequency of HLA alleles in the Romanian population. Immunogenetics 2016;68:167-78. [PMID: 26711124 DOI: 10.1007/s00251-015-0891-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
89 Pan LP, Zhang W, Zhang L, Wu XP, Zhu XL, Yan BY, Li JY, Xu AQ, Liu Y, Li H. CD3Z genetic polymorphism in immune response to hepatitis B vaccination in two independent Chinese populations. PLoS One 2012;7:e35303. [PMID: 22536368 DOI: 10.1371/journal.pone.0035303] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
90 Pan L, Zhang W, Liang Z, Wu X, Zhu X, Li J, Li T, Wang L, Li H, Liu Y. Association between polymorphisms of the cytokine and cytokine receptor genes and immune response to hepatitis B vaccination in a Chinese Han population. J Med Virol. 2012;84:26-33. [PMID: 22052597 DOI: 10.1002/jmv.22251] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]